Neuronal Cytoskeleton Regulation and Neurodegeneration

  • Ya-Li Zheng
  • Niranjana D. Amin
  • Parvathi Rudrabhatla
  • Sashi Kesavapany
  • Harish C. Pant


The biology of neurodegeneration program evolved from the laboratory studying the basic biology of neuronal cytoskeletal protein phosphorylation during development and normal function in the adult. To understand the molecular basis of neurodegeneration, our major focus has been to study the regulation of compartment-specific patterns of cytoskeletal protein phosphorylation in neuronal perikarya and axons. We have demonstrated that the phosphorylation of the numerous acceptor sites on proline-directed serine and thronine (Pro-Ser/Thr) residue proteins such as tau and neurofilaments is tightly regulated. The phosphorylation of these molecules is generally confined to the axonal compartment. It was recognized that in neurodegenerative disorders such as Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS), the pathology was characterized by an accumulation of aberrantly phosphorylated cytoskeletal proteins in cell bodies, suggesting that topographic regulation had been compromised. This led inevitably into studies of neurodegeneration in cell culture and model mice with emphasis on a specific neuronal protein kinases, for example, cyclin-dependent kinase 5 (Cdk5), that target numerous neuronal proteins including cytoskeletal proteins, which when deregulated may be responsible for the pathology seen in neurodegeneration. In cell systems, neuronal stress leads to deregulated kinases, for example, Cdk5, accompanied by abnormal cytoskeletal protein phosphorylation and cell death characteristic of neurodegeneration. In this chapter, efforts are made to answer some of the following questions. (1) How is the cytoskeletal protein phosphorylation topographically and stably regulated in their proline-directed Ser/Thr residues in neurons? (2) What factors are responsible for the regulation and deregulation of Cdk5 in neurons?


Amyotrophic Lateral Sclerosis Cytoskeletal Protein Tail Domain Squid Giant Axon Topographic Regulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



cyclin-dependent kinase 5


epidermal growth factor


glycogen synthase kinase 3


extracellular signal-regulated kinases 1 and 2


mitogen-activated protein kinase


protein interacting with NIMA (never in mitosis A)-1


phosphorylated neurofilament-high molecular weight subunit.



This work is supported by the Intramural Research Program of the NINDS, National Institutes of Health.


  1. 1.
    Grant P, Diggins M, Pant HC (1999) Topographic regulation of cytoskeletal protein phosphorylation by multimeric complexes in the squid giant fiber system. J Neurobiol 40:89–102PubMedCrossRefGoogle Scholar
  2. 2.
    Nixon RA, Paskevich PA, Sihag RK, Thayer CY (1994) Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber. J Cell Biol 126:1031–1046PubMedCrossRefGoogle Scholar
  3. 3.
    Pant HC, Veeranna (1995) Neurofilament phosphorylation. Biochem Cell Biol 73:575–592PubMedCrossRefGoogle Scholar
  4. 4.
    Grant P, Pant HC (2000) Neurofilament protein synthesis and phosphorylation. J Neurocytol 29:843–872PubMedCrossRefGoogle Scholar
  5. 5.
    Hellmich MR, Pant HC, Wada E, Battey JF (1992) Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci USA 89:10867–10871PubMedCrossRefGoogle Scholar
  6. 6.
    Shetty KT, Kaech S, Link WT (1995) Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. J Neurochem 64:1988–1995PubMedCrossRefGoogle Scholar
  7. 7.
    Pant AC, Veeranna , Pant HC, Amin N (1997) Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5). Brain Res 765:259–266PubMedCrossRefGoogle Scholar
  8. 8.
    Zheng YL, Li BS, Veeranna , Pant HC (2003) Phosphorylation of the head domain of neurofilament protein (NF-M): a factor regulating topographic phosphorylation of NF-M tail domain KSP sites in neurons. J Biol Chem 278:24026–24032PubMedCrossRefGoogle Scholar
  9. 9.
    Jaffe H, Veeranna , Pant HC (199a) Characterization of serine and threonine phosphorylation sites in beta-elimination/ethanethiol addition-modified proteins by electrospray tandem mass spectrometry and database searching. Biochemistry 37:16211–16224CrossRefGoogle Scholar
  10. 10.
    Jaffe H, Veeranna , Shetty KT, Pant HC (199b) Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray ionization tandem mass spectrometry and database searching. Biochemistry 37:3931–3940CrossRefGoogle Scholar
  11. 11.
    Dashiell SM, Tanner SL, Pant HC, Quarles RH (2002) Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J Neurochem 81:1263–1272PubMedCrossRefGoogle Scholar
  12. 12.
    de Waegh SM, Lee VM, Brady ST (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451–463PubMedCrossRefGoogle Scholar
  13. 13.
    Kirkpatrick LL, Brady ST (1994) Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. J Neurosci 14:7440–7450PubMedGoogle Scholar
  14. 14.
    Veeranna, Amin ND, Ahn NG (1998) Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 18:4008–4021PubMedGoogle Scholar
  15. 15.
    Li BS, Veeranna, Grant P, Pant HC (1999a) Calcium influx and membrane depolarization induce phosphorylation of neurofilament (NF-M) KSP repeats in PC12 cells. Brain Res Mol Brain Res 70:84–91CrossRefGoogle Scholar
  16. 16.
    Li BS, Veeranna, Gu J, Grant P, Pant HC (1999) Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells. Eur J Biochem 262:211–217PubMedCrossRefGoogle Scholar
  17. 17.
    Li BS, Zhang L, Gu J, Amin ND, Pant HC (2000) Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J Neurosci 20:6055–6062PubMedGoogle Scholar
  18. 18.
    Paglini G, Pigino G, Kunda P (1998) Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J Neurosci 18:9858–9869PubMedGoogle Scholar
  19. 19.
    Weiwad M, Werner A, Rucknagel P, Schierhorn A, Kullertz G, Fischer G (2004) Catalysis of proline-directed protein phosphorylation by peptidyl-prolyl cis/trans Isomerases. J Mol Biol 339:635–646PubMedCrossRefGoogle Scholar
  20. 20.
    Wulf G, Finn G, Suizu F, Lu KP (2005) Phosphorylation-specific prolyl isomerization: is there an underlying theme. Nat Cell Biol 7:435–441PubMedCrossRefGoogle Scholar
  21. 21.
    Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP (2002) Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J Biol Chem 277:2381–2384PubMedCrossRefGoogle Scholar
  22. 22.
    Kesavapany S, Patel V, Zheng YL (2007) Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons. Mol Biol Cell 18:3645–3655PubMedCrossRefGoogle Scholar
  23. 23.
    Davis DR, Brion JP, Couck AM (1995) The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem J 309:941–949PubMedGoogle Scholar
  24. 24.
    Brownlees J, Yates A, Bajaj NP (2000) Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113:401–407PubMedGoogle Scholar
  25. 25.
    Shea TB, Zheng YL, Ortiz D, Pant HC (2004) Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress. J Neurosci Res 76:795–800PubMedCrossRefGoogle Scholar
  26. 26.
    Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, Diaz-Nido J (1999) Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration, FEBS Lett 453:260–264PubMedCrossRefGoogle Scholar
  27. 27.
    Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M (2004) Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297:186–196PubMedCrossRefGoogle Scholar
  28. 28.
    Maccioni RB, Otth C, Concha II, Munoz JP (2001) The protein kinase Cdk5: structural aspects, roles in neurogenesis and involvement in Alzheimer’s pathology. Eur J Biochem 268:1518–1527PubMedCrossRefGoogle Scholar
  29. 29.
    Quintanilla RA, Orellana DI, González-Billault C, Maccioni RB (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 295:245–257PubMedCrossRefGoogle Scholar
  30. 30.
    Ko J, Humbert S, Bronson RT (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758–6771PubMedGoogle Scholar
  31. 31.
    Shetty KT, Kaech S, Link WT (1995) Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. J Neurochem 64:1988–1995PubMedCrossRefGoogle Scholar
  32. 32.
    Grant P, Sharma P, Pant HC (2001) Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism. Eur J Biochem 268:1534–1546PubMedCrossRefGoogle Scholar
  33. 33.
    Ohshima T, Ward JM, Huh CG (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173–11178PubMedCrossRefGoogle Scholar
  34. 34.
    Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH (1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18:29–42PubMedCrossRefGoogle Scholar
  35. 35.
    Tanaka T, Veeranna, Ohshima T (2001) Neuronal cyclin-dependent kinase 5 activity is critical for survival. J Neurosci 21:550–558PubMedGoogle Scholar
  36. 36.
    Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615–622PubMedCrossRefGoogle Scholar
  37. 37.
    Bu B, Li J, Davies P, Vincent I (2002) Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci 22:6515–6525PubMedGoogle Scholar
  38. 38.
    Whitmarsh AJ, Davis RJ (1998) Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem Sci 23:481–485PubMedCrossRefGoogle Scholar
  39. 39.
    Hunter T (2000) Signaling – 2000 and beyond. Cell 100:113–127PubMedCrossRefGoogle Scholar
  40. 40.
    Greengard P (2001) The neurobiology of slow synaptic transmission. Science 294:1024–1030PubMedCrossRefGoogle Scholar
  41. 41.
    Greengard P (2001) The neurobiology of dopamine signaling. Biosci Rep 21:247–269PubMedCrossRefGoogle Scholar
  42. 42.
    Grant SG, O’Dell TJ (2001) Multiprotein complex signaling and the plasticity problem. Curr Opin Neurobiol 11:363–368PubMedCrossRefGoogle Scholar
  43. 43.
    Wills Z, Bateman J, Korey CA, Comer A, Van Vactor D (1999) The tyrosine kinase Abl and its substrate enabled collaborate with the receptor phosphatase Dlar to control motor axon guidance. Neuron 22:301–312PubMedCrossRefGoogle Scholar
  44. 44.
    Barford D, Das AK, Egloff MP (1998) The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27:133–164PubMedCrossRefGoogle Scholar
  45. 45.
    Saito T, Shima H, Osawa Y (1995) Neurofilament-associated protein phosphatase 2A: its possible role in preserving neurofilaments in filamentous states. Biochemistry 34:7376–7384PubMedCrossRefGoogle Scholar
  46. 46.
    Merrick SE, Trojanowski JQ, Lee VM (1997) Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci 17:5726–5737PubMedGoogle Scholar
  47. 47.
    Strack S, Westphal RS, Colbran RJ, Ebner FF, Wadzinski BE (1997) Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res Mol Brain Res 49:15–28PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Ya-Li Zheng
    • 1
  • Niranjana D. Amin
    • 1
  • Parvathi Rudrabhatla
    • 1
  • Sashi Kesavapany
    • 1
  • Harish C. Pant
    • 1
  1. 1.Cytoskeletal Protein Regulation Section, Laboratory of NeurochemistryNINDS, NIHBethesda

Personalised recommendations